Glasgow 2024: Double dose start for oral PrEP in new European guidelines – rapid protection in two hours
14 November 2024. Related: Conference reports, Guidelines, HIV prevention and transmission.
2024
Liverpool University Drug Interaction website recognised for global impact on research and care
14 November 2024. Related: Conference reports, PK and drug interactions, Treatment advocacy.
Glasgow 2024: Once-weekly oral ART with islatravir plus lenacapavir sustains results to week 48
14 November 2024. Related: Conference reports, Antiretrovirals.
Once-weekly oral ART: islatravir plus lenacapavir 48 week results in phase 2 switch study
13 November 2024. Related: Other news.
Glasgow HIV Congress 2024
10 November 2024. Related: Early access, Conference reports.
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024. Related: Early access, Book and film reviews.
WHO toolkit to strengthen engagement of health workers in emergency responses
5 November 2024. Related: On the web.
HTB news: i-Base changes during 2024
1 November 2024. Related: Editorial, Special reports.
Bipolar disorder in people living with HIV
1 November 2024. Related: Early access, Coinfections and complications.
Mpox breakthrough cases after two doses of the MVA-BN vaccine
1 November 2024. Related: Early access, mpox (monkeypox).
Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic
1 November 2024. Related: Early access, Treatment access, Paediatric care, Drug resistance.
Future meetings and webinars 2024/2025
1 November 2024. Related: Future meetings.
Confirmed mpox clade 1b case in Germany: risk remains low for EU/EEA
23 October 2024. Related: mpox (monkeypox).
Helsinki Declaration: 2024 edition upholds ethical access to treatment
23 October 2024. Related: Treatment access, HIV prevention and transmission.
Lack of tecovirimat activity against mpox clade 1
21 October 2024. Related: mpox (monkeypox), Coinfections and complications.
Efficacy of MVA-BN vaccine: systematic review
21 October 2024. Related: mpox (monkeypox).
Kidney transplants from HIV positive donors to HIV recipients
17 October 2024. Related: Coinfections and complications, Cancer and HIV.
US NIAID updates HIV guide to person-centred language
17 October 2024. Related: Treatment advocacy, Book and film reviews, On the web.
Long COVID essentials: link to online resources
15 October 2024. Related: On the web, COVID-19.
Urgency of planning broad vaccine-like access to lenacapavir PrEP globally
13 October 2024. Related: Conference reports, Treatment access, HIV prevention and transmission.
Impact on CD4 counts of once-monthly islatravir in PrEP studies: early macaque results with MK-8527 follow-on compound
9 October 2024. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Lenacapavir PrEP in cisgender gay men, trans and gender-diverse people: results of the PURPOSE 2 study
9 October 2024. Related: Conference reports, HIV prevention and transmission.
HIVR4P 2024: Context of PrEP in Latin America
7 October 2024. Related: Conference reports, Treatment access, HIV prevention and transmission.
HIVR4P 2024: Introduction
7 October 2024. Related: Conference reports, Treatment access, HIV prevention and transmission.
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
6 October 2024. Related: Special reports.
Mpox outbreak in Australia: half of cases had previously received a vaccine
3 October 2024. Related: mpox (monkeypox).
Gilead announces plans to support generic lenacapavir for low-income countries
2 October 2024. Related: Treatment access.
WHO situation report on mpox
2 October 2024. Related: mpox (monkeypox).
Major update of UK PrEP guidelines online for public consultation
1 October 2024. Related: Special reports, Guidelines, HIV prevention and transmission.
NICE defers decision on CAB-LA as PrEP needing more information
27 September 2024. Related: Treatment access, HIV prevention and transmission.
Second lenacapavir PrEP study protected 99.9% of people in the PURPOSE 2 trial: ACT UP London challenge pricing
26 September 2024. Related: HIV prevention and transmission.
UNAIDS reports debt crisis obstructs HIV response
19 September 2024. Related: Treatment access, Other news.
i-Base library archived at the Bishopsgate Institute and Wellcome Collection
17 September 2024. Related: Treatment advocacy, Other news.
New HIV drug interactions, statin resource and free hybrid workshop
17 September 2024. Related: PK and drug interactions.
UK orders 150,000 doses of MVA-BN mpox vaccine
16 September 2024. Related: mpox (monkeypox).
ART, weight changes and obesity: results from CASCADE cohort
16 September 2024. Related: Side effects, Lipodystrophy and metabolic complications.
Activist pin-up calendar from ACT UP London
11 September 2024. Related: Treatment advocacy, Book and film reviews, Other news.
AIDS 2024: Including people living with HIV in non-HIV research
11 September 2024. Related: Conference reports, Treatment access, Cancer and HIV, Treatment advocacy.
New guidelines for HIV-related lymphoma
3 September 2024. Related: Guidelines.
Responses to mpox clade 1b emergency: webinar details
1 September 2024. Related: mpox (monkeypox).
IAS 2024: Open letter to IAS over online access
1 September 2024. Related: Editorial, Conference reports.
WHO declares new mpox emergency (clade 1b): tecovirimat not effective in DRC study
16 August 2024. Related: mpox (monkeypox).
AIDS 2024: Ten early reports
12 August 2024. Related: Conference reports, Antiretrovirals.
BMS to discontinue atazanavir/cobicistat (Evotaz) in September 2024
12 August 2024. Related: Antiretrovirals.
Five days on two days off: Biktarvy in pilot FOTO study
12 August 2024. Related: Conference reports, Antiretrovirals.
Subcutaneous formulation of long-acting CAB/RPV discontinued
10 August 2024. Related: Conference reports, Antiretrovirals.
First data on third-generation integrase inhibitor from ViiV
10 August 2024. Related: Conference reports, Antiretrovirals.
Switching to daily oral bictegravir and lenacapavir dual therapy to simplify ART in ARTISTRY-1 study
10 August 2024. Related: Conference reports, Antiretrovirals.
AIDS 2024: Lenacapavir as PrEP is “beyond wonderful” but PURPOSE 1 study tells us so much more
29 July 2024. Related: Conference reports, HIV prevention and transmission.
Low efficacy and high price of dapivirine ring: not included as PrEP in South African guidelines
27 July 2024. Related: Guidelines, HIV prevention and transmission.
Semaglutide in people with HIV: reduces both central and peripheral fat worsening lipoatrophy
27 July 2024. Related: Side effects, Lipodystrophy and metabolic complications.
Lenacapavir could be produced for $40 a year: 1000-fold lower than current US price for treating MDR HIV
26 July 2024. Related: Conference reports, Treatment access, HIV prevention and transmission.
Updated WHO guidelines for HIV PEP (July 2024)
23 July 2024. Related: Guidelines, HIV prevention and transmission.
AIDS 2024: Introduction to AIDS 2024
22 July 2024. Related: Conference reports.
UNAIDS report: The urgency of now – AIDS at a crossroads.
22 July 2024. Related: Conference reports, Treatment advocacy.
New community call to challenge social settings that drive HIV-related stigma
20 July 2024. Related: Conference reports, HIV prevention and transmission, Treatment advocacy.
HIV research to watch out for at the AIDS 2024 conference
18 July 2024. Related: Conference reports.
CHAI six-monthly market report (July 2024)
16 July 2024. Related: Treatment access, On the web.
New US screening guidelines to reduce risk of anal cancer in people living with HIV
12 July 2024. Related: Guidelines, Coinfections and complications.
HIV pipeline: global overview for people in LMICs
11 July 2024. Related: Antiretrovirals, On the web.
i-Base printed resources: please order now while stocks last
1 July 2024. Related: Editorial.
Lenacapavir PrEP: 100% efficacy in cisgender women sets new challenges for global pricing and access
24 June 2024. Related: HIV prevention and transmission.
CHIVA resources for children living with HIV
13 June 2024. Related: Paediatric care, On the web.
CROI 2024 final reports: statins, doxy-PEP and TAF implant
10 June 2024. Related: Conference reports, Coinfections and complications.
Doxy-PEP studies at CROI 2024
9 June 2024. Related: Conference reports, Coinfections and complications.